- Home
- MDIA vs ESLA Comparison
MDIA vs ESLA Comparison
Compare MDIA & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDIA | ESLA |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 60.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MDIA | ESLA |
|---|---|---|
| Price | $0.61 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 30.3K | ★ 374.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $95,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 195.05 | N/A |
| 52 Week Low | $0.54 | $0.73 |
| 52 Week High | $1.60 | $3.15 |
Technical Indicators
Market Signals| Indicator | MDIA | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 46.96 |
| Support Level | $0.56 | $0.86 |
| Resistance Level | $0.65 | $1.18 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 78.96 | 51.87 |
Price Performance
Historical ComparisonAbout MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.